HST
39
-3
BA
47
2
VMC
53
-4
DIS
85
3
XOM
42
-6
BSX
64
-3
HCP
56
-8
INTC
41
4
BK
74
3
VZ
44
4
IPG
34
-9
RL
69
-4
MAS
52
-4
AAPL
40
-6
MDLZ
32
-4
HPE
44
-2
WHR
65
-5
STT
64
2
CMS
60
2
CNP
54
10
HST
39
-3
BA
47
2
VMC
53
-4
DIS
85
3
XOM
42
-6
BSX
64
-3
HCP
56
-8
INTC
41
4
BK
74
3
VZ
44
4
IPG
34
-9
RL
69
-4
MAS
52
-4
AAPL
40
-6
MDLZ
32
-4
HPE
44
-2
WHR
65
-5
STT
64
2
CMS
60
2
CNP
54
10
Financhill
Back

ProShares Ultra VIX Short-Term Futures Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
19

UVXY
ProShares Ultra VIX Short-Term Futures

Last Price:
22.10
Seasonality Move:
-14.51%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
19
ProShares Ultra VIX Short-Term Futures (UVXY) is a Sell

Is ProShares Ultra VIX Short-Term Futures a Buy, Sell or Hold?

  • The current ProShares Ultra VIX Short-Term Futures [UVXY] share price is $22.10. The Score for UVXY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • UVXY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UVXY Stock Price Chart

What is ProShares Ultra VIX Short-Term Futures's stock price today?

  • The ProShares Ultra VIX Short-Term Futures share price today is $22.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UVXY is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

UVXY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.73 Sell
Relative Strength Index (14 RSI): 42.02 Sell
Chaikin Money Flow: 3482480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.14 - 28.72) Sell
Bollinger Bands (100): (20.55 - 31.59) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

UVXY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.98 Buy
20-day SMA: 25.03 Sell
50-day SMA: 25.79 Sell
200-day SMA: 28.86 Sell
8-day EMA: 21.87 Buy
20-day EMA: 23.95 Sell
50-day EMA: 25.45 Sell
200-day EMA: 40.2 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ProShares Ultra VIX Short-Term Futures Earnings Growth & UVXY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ProShares Ultra VIX Short-Term Futures Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):